Aurobindo Pharma Limited (BOM:524804)
India
· Delayed Price · Currency is INR 1,166.30
+9.20 (0.80%)
At close: Mar 27, 2025
Aurobindo Pharma Employees
Aurobindo Pharma had 26,015 employees as of March 31, 2024. The number of employees increased by 2,564 or 10.93% compared to the previous year.
Employees
26,015
Change (1Y)
2,564
Growth (1Y)
10.93%
Revenue / Employee
11.89M INR
Profits / Employee
1.34M INR
Market Cap
658.72B
Employees Chart
Related Stocks
| Company Name | Employees |
|---|---|
| Reliance Industries | 347,362 |
| HDFC Bank | 213,527 |
| Tata Consultancy Services | 601,546 |
| Bharti Airtel | 23,628 |
| ICICI Bank | 187,765 |
| State Bank of India | 232,296 |
| Infosys | 317,240 |
| Bajaj Finance | 43,147 |
Aurobindo Pharma News
- 27 days ago - Aurobindo Pharma terminates vaccine license agreement with Hilleman Laboratories - Business Upturn
- 4 weeks ago - Stocks to watch today: AstraZeneca, Glenmark, Aurobindo Pharma, Mankind Pharma, Bayer Crop in pharma updates - Business Upturn
- 5 weeks ago - Aurobindo Pharma USA’s warehouse receives OAI status with five observations from US FDA - Business Upturn
- 5 weeks ago - Pharma stocks drop up to 7% after Trump announces 25% tariff on imports - Business Upturn
- 5 weeks ago - Aurobindo shares fall 7% as US FDA issues 5 observations on pre-approval inspection for Andhra unit - Business Upturn
- 6 weeks ago - US FDA completes action with 5 observations for Aurobindo Pharma’s Eugia Steriles facility - Business Upturn
- 6 weeks ago - Pharma stocks rally: Aurobindo Pharma up 4.05%, Lupin jumps 3.81%, Biocon gains 2.80% at market open - Business Upturn
- 7 weeks ago - Aurobindo Pharma’s API Unit 2 in Telangana receives VAI classification from US FDA, EIR issued - Business Upturn